Title: Study of BISAP Score in Evaluation of Acute Pancreatitis and Its Severity
Authors: Dr Balaji Chittipotula, Dr Mahesh Babu Ch, Dr S V Satyanarayana Rao, Dr P Ashok Teja
DOI: https://dx.doi.org/10.18535/jmscr/v8i1.174
Abstract
Back ground: Multiple risk stratification tools for acute pancreatitis have been developed, but their clinical usefulness is limited. In Ranson's criteria and modified Glasgow score there are multiple parameters, of which some of them are not available in majority of hospitals in India. In addition, both are assessed after 48hrs, thereby missing potentially valuable early therapeutic window. The APACHE II score requires collection of large number of parameters some of which may not be relevant to prognosis. For this purpose, a simple and accurate clinical scoring system that is, Bedside Index for Severity in Acute Pancreatitis (BISAP) scoring system was developed. This scoring system is used for stratifying patients according to their risk of mortality and is able to identify patients at increased risk of mortality prior to the onset of organ failure. More over the data for BISAP score is collected within the first 24hrs of hospitalization. The ability to stratify patients early in their course is a major step in improving future management strategies in acute pancreatitis.
Materials and Methods: 50 patients admitted from November 2017 to January 2019 with acute pancreatitis were included in the study. BISAP score was calculated in all such patients, based on the data obtained within 24hrs of hospitalization. Patients were assessed for organ failure according to Marshall scoring system and followed throughout hospitalization for assessment of complications. Statistical analyses were made using Fischer’s exact probability test. The difference was assumed statistically significant when p< 0.05.
Results: There was a statistically highly significant trend for increasing mortality (p< 0.05) and intermediate markers of severity (p<0.05) that is transient organ failure, persistent organ failure and pancreatic necrosis with BISAP score ≥3.
Conclusion: The BISAP score represents a simple way to identify patients at risk of increased mortality and the development of intermediate markers of severity within 24 hours of presentation.
